STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Akoya to Report First Quarter 2021 Financial Results on May 18, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Akoya Biosciences (Nasdaq: AKYA) will release its first quarter 2021 financial results after market close on May 18, 2021. Management will discuss these results during a conference call scheduled for 5:00 p.m. ET. Investors can participate by calling (833) 562-0146 domestically or (661) 567-1226 internationally, using Conference ID: 7824008. A live and archived webcast will also be available on the Akoya website.

Akoya is known for its spatial biology solutions, including CODEX® and Phenoptics™ platforms, which allow researchers to explore cell interactions in health and disease.

Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2021 after the market close on Tuesday, May 18, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (833) 562-0146 for domestic callers or (661) 567-1226 for international callers, followed by Conference ID: 7824008. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Investor Contact:
David Deuchler
Gilmartin Group LLC
investors@akoyabio.com

Media Contact:
Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com


FAQ

When will Akoya Biosciences release its Q1 2021 financial results?

Akoya Biosciences will release its Q1 2021 financial results on May 18, 2021.

What time is the Akoya Biosciences conference call for financial results?

The conference call will take place at 5:00 p.m. ET on May 18, 2021.

How can I listen to the Akoya Biosciences conference call?

Investors can listen by calling (833) 562-0146 for domestic and (661) 567-1226 for international calls, using Conference ID: 7824008.

Where can I find the Akoya Biosciences conference call webcast?

The live and archived webcast will be available on the 'Investors' section of the Akoya website.

What platforms does Akoya Biosciences offer?

Akoya offers the CODEX® and Phenoptics™ platforms for spatial phenotyping in research.

Akoya BioSciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

106.13M
25.62M
11.09%
70.19%
3.24%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
MARLBOROUGH